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Abstract
Members of the NR1I subfamily of nuclear receptors play a role in the transcriptional activation of genes involved in drug metabolism and
transport. NR1I3, the constitutive androstane receptor (CAR), mediates the induction of several genes involved in drug response, including
members of the CYP3A, CYP2B and UGT1A subfamilies. Large inter-individual variation in drug clearance has been reported for many drug
metabolising enzyme genes. Sequence variation at the CAR locus could potentially contribute to variation in downstream targets, as well as
to the substantial variation in expression level reported. We used a comparative genomics-based approach to select resequencing segments
in 70 subjects from three populations. We identiﬁed 21 polymorphic sites, one of which results in an amino acid substitution. Our study
reveals a common haplotype shared by all three populations which is remarkably similar to the ancestral sequence, conﬁrming that CAR is
under strong functional constraints. The level and pattern of sequence variation is approximately similar across populations, suggesting that
interethnic differences in drug metabolism are not likely to be due to genetic variation at the CAR locus. We also identify several common
non-coding variants that occur at highly conserved sites across four major branches of the mammalian phylogeny, suggesting that they may
affect CAR expression and, ultimately, the activity of its downstream targets.
Keywords: pharmacogenetics, nuclear receptors, haplotype structure, sequence variation
Introduction
The constitutive androstane receptor (CAR, NR1I3) belongs
to the NR1I subfamily of nuclear receptors (NRs), members
of which play a role in transcriptional activation of genes
involved in drug metabolism and transport. Other members of
the NR1I subfamily include the pregnane X receptor (PXR,
NR1I2) and the vitamin D receptor (VDR, NR1I1). CAR is
expressed in the liver and intestine and, through heterodi-
merisation with the retinoic acid receptor (RXR), mediates
the induction of important drug metabolising enzyme (DME)
genes such as CYP3A4, CYP2B6 and UGT1A1,
1 as well as
drug transport genes including multidrug resistance-associated
protein 2 (MRP2).
2 In addition, CAR enhances the metabolic
clearance of endogenous bile acids and bilirubin, protecting
against toxicity,
3,4 and has recently been implicated in thyroid
hormone regulation.
5
By contrast with PXR, which is found in a variety of species
including ﬁsh — and is able to bind a diverse variety of
exogenous and endogenous ligands, including bile salts,
6
CAR has only been identiﬁed in mammals and is activated
by a much smaller set of ligands.
7 Interestingly, only one
xenosensor gene has been identiﬁed in non-mammalian
species, such as chicken
8 and pufferﬁsh.
9 The protein
sequences of the chicken and pufferﬁsh xenosensor genes are
roughly equally related to those of mammalian PXR and CAR
sequences.
10 Handschin et al. used several experimental
approaches to conﬁrm that the chicken has only one xeno-
sensor gene, CXR, but were unable to identify additional
genes, suggesting that CXR represents the ancestral gene that
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environmental and nutritional factors.
10
CAR genes have been sequenced from a total of eight
mammals, including the partial sequences of cow and dog
analysed in this study. CAR has the typical nuclear hormone
receptor organisation of an amino-terminal DNA binding
domain (DBD) and a carboxy-terminal ligand binding domain
(LBD); however, in comparing CAR sequences among
mammals, a striking feature is high cross-species sequence
divergence in the LBD.
11,12 The LBD of CAR shares amino
acid identities of only 74–79 per cent between human and
rodent sequences, which are unusually low when compared
with other NRs.
11,12
The variation in the LBD of CAR is more striking when
DNA sequences are analysed, in particular by comparing the
rateofnon-synonymous(resulting inanaminoacidchange)and
synonymous (not resulting in an amino acid change) nucleotide
substitution rates. The rates of non-synonymous substitution
normalised to the synonymous substitution rate, dN/dS (v), for
CAR and PXR are 5.6 and 4.0 times higher than the average
for other NR genes, respectively.
12 The elevated v ratios of the
CAR and PXR LBDs suggest adaptive evolution
13 and may be
explained in part by the biological role played by CAR and
PXR in the metabolism of different xenobiotic and environ-
mental substances,
11,12 although the nature of such ligands is
currently unknown. Relaxation of functional constraints may
also explain the elevated v values at CAR and PXR, but this
seemslessplausible,giventheircriticalroleinactivating enzyme
genes involved in the metabolism of important endogenous and
exogenous compounds.
The role of NRs (especially PXR and CAR) in the
regulation of genes involved in drug metabolism is of par-
ticular importance to clinical pharmacology. Substantial
interindividual variation in mRNA expression level has been
reported for CAR.
14,15 The hepatic enzyme CYP3A4 —
which is believed to play a signiﬁcant role in adult drug
metabolism — exhibits wide variation in gene expression and
activity, only partially explained by known genetic variants.
16
For CYP2B6, which is also regulated by CAR, large inter-
individual variabilities in mRNA level and activity have been
reported.
17,18 Strong positive correlations in mRNA levels
have been observed between CAR and CYP3A4,
19 as well as
CAR and CYP2B6,
14,15 suggesting that the interindividual
variability observed for some DME genes could be associated
with variability in upstream regulators such as CAR. A better
understanding of sequence variation in regulatory genes such
as CAR, PXR or RXR, could conceivably explain increased or
decreased expression and/or activity proﬁles of DME genes.
We characterised patterns of genetic variation in three
ethnically diverse human population samples through a rese-
quencing survey of CAR coding regions and conserved
non-coding sequences (CNSs). Our study reveals a common
haplotype shared by all three populations which is strikingly
similar to the ancestral sequence, conﬁrming that CAR is
under strong functional constraints. In addition, the level and
pattern of sequence variation is approximately similar across
populations, suggesting that interethnic differences in drug
response are not due to genetic variation in CAR. We also
identify several common non-coding variants that occur at
highly conserved sites across four major branches of the
mammalian phylogeny, suggesting that they may affect CAR
expression and, in turn, the activity of its downstream targets.
Methods
Re-sequencing survey design
Human primer sequences were designed based on the reverse
complement of Genbank accession number AL509714. CAR
human genomic sequence (AL509714) was aligned with
orthologous chimpanzee (AADA01309121), dog
(AAEX01049487 and AAEX01049488), cow (Scaffold 30573,
10th December, 2004), rat (AB105071) and mouse
(AC084821) sequences using PipMaker.
20 All exons were
included in the resequencing survey, along with intronic
CNSs. The human genomic sequence was analysed using
Cluster Buster
21 in order to predict clusters of the following
liver-enriched transcription factors: HNF1a, HNF4, PXR/
CAR, OCT-1, PPAR/RXR, CEBP, HNF3b, HNF4/
COUP-TF. One region predicted by Cluster Buster with a
high probability falls approximately 11kilobases (kb) upstream
of CAR and was included in the survey.
Population samples
Human population samples included 24 European individuals
from the Centre d’Etude du Polymorphisme Humain families,
23 individuals from the Human Variation Panel of African
Americans and 23 individuals from the Human Variation Panel
of the Han People of Los Angeles. All DNA samples were
obtained from the Coriell Cell Repository. Sample infor-
mation can be found in PharmGKB (http://www.pgkb.org),
as well as at the Di Rienzo laboratory website (http://genapps.
uchicago.edu/labweb/programss.html). One Western chim-
panzee (Pan troglodytes verus) was sequenced for use as an
outgroup.
This study was carried out in accordance with the
Declaration of Helsinki (2000) of the World Medical Associ-
ation and was approved by the Institutional Review Board of
the University of Chicago.
Polymerase chain reaction (PCR)
ampliﬁcation and sequencing
Primer sequences and conditions are available in PharmGKB
and at the Di Rienzo laboratory website. PCR and sequencing
were performed as described elsewhere.
22 The same primers
were used to amplify the human and chimpanzee samples.
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Summary statistics of DNA sequence variation were calculated
using SLIDER. Haplotypes were inferred using PHASE2
23,24
in each population sample separately. FST, a measure of allele
frequency variation among samples, was calculated between all
pairwise combinations of populations for each polymorphic
site.
25 Individual transcription factor binding sites were pre-
dicted using the liver-speciﬁc proﬁles available with Match
1.0.
26 Sorting Intolerant From Tolerant (SIFT)
27, version 2
was used to predict the consequence of the single amino acid
substitution. Given an amino acid sequence, SIFT searches for
and performs alignments of similar sequences, then calculates
the probabilities for amino acid changes affecting protein
function based on cross-species conservation at each position.
ESEﬁnder was used to predict the locations of exon splice
enhancers.
28 Human sequence comprising the entire rese-
quenced region was aligned to the genomic sequences from
the ﬁve mammalian species listed above using Multi-Lagan.
29
Phylogenetic analysis by
maximum likelihood
Sequences were aligned with Clustal X. Estimation of v ratios
was carried out by maximum likelihood using a codon-based
substitution model in Phylogenetic Analysis by Maximum
Likelihood (PAML) version 3.13.
30 The input to PAML is a
treeﬁle of the phylogeny of the sequences to be studied and a
ﬁle with aligned sequences. The phylogeny is based on the
known phylogenetic relationships between the species to be
studied, determined by a consensus of morphological and
molecular data.
PAML can determine estimates of v for models of varying
complexity. The most commonly applied models are as follows
(the PAML model numbers are shown in parentheses; ‘sites’
refers to codons):
31,32 model M0 (null model with a single v
ratio among all sites); M3 (‘discrete’ model, with two or more
categories of sites with the v ratio free to vary for each site);
M7 (‘beta model’, ten categories of sites with ten v ratios in
the range 0–1 taken from a discrete approximation of the beta
distribution); and M8 (‘beta plus v model, ten categories of
sites from a beta distribution as in M7 plus an additional cat-
egory of sites with a v ratio that is free to vary from 0 to
greater than 1). PAML estimates the v ratios that are allowed
to vary in these models, as well as the proportion of sites
(codons) with each ratio.
Of the PAML models listed above, only M3 and M8 can
detect positive selection (ie v . 1). Each PAML model gen-
erates a log-likelihood, indicating how well the models ﬁt the
input data. Some PAML models are ‘nested’ within each other
(eg M0 within M3, M7 within M8). In those cases, twice the
log-likelihood difference between the two models is compared
with a x
2 distribution with degrees of freedom equal to the
difference in degrees of freedom between the two models;
p values for sites potentially under positive selection are
obtained using a Bayesian approach in PAML.
33 The accuracy
and power of PAML models increases with more sequences
and longer-length sequences.
34 Simpler PAML models are
preferred unless a more complex model ﬁts the observed data
signiﬁcantly better.
Analysis was performed on programslicly available coding
sequences, either from cDNA sequences or predicted from
genomic DNA sequences. Four other genes in the NR1
family of NRs were chosen for comparison with CAR: the
gene encoding thyroid receptor-a (TRa), the gene encoding
farnesoid X receptor (FXR), VDR and PXR. These genes all
have sequence data for four or more mammalian species. VDR
and PXR are the genes most closely related to CAR; these
three genes are classiﬁed in the NR1I subfamily. Separate
PAML analyses were performed on datasets of full-length
sequence and restricted to either DBD or LBD, the two major
domains of NRs. Information regarding all sequences used for
PAML analysis can be found in Supplementary Table 1.
Results
Survey design and summary statistics
The design of the resequencing survey was based in part on
cross-species sequence conservation, as shown in Figure 1.
The total evolutionary time spanned by the six mammalian
species represented in the alignment is greater than 370 million
years.
35 Thus, elements showing a high degree of sequence
similarity across this set of species are more likely to be due to
active conservation resulting from functional constraints (eg
regulation of CAR expression) rather than limited divergence
time. The predicted gene located downstream of the CAR
Figure 1. MultiPipMaker plot illustrating sequence conservation
at the CAR locus. The vertical axis ranges between 50 per cent
and 100 per cent sequence identity; areas within the plot
shaded in pink correspond to the exons of CAR and those
shaded in yellow correspond to exons of the predicted protein
FLJ12770. Bars along the bottom indicate the segments included
in the resequencing survey. Numbers across the bottom indi-
cate the position relative to the reverse-complemented refer-
ence sequence (AL50974).
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account for some of the increased sequence identity ﬂanking
CAR exon 9 (Figure 1). BLASTing the mRNA sequences of
the two genes against one another indicates that the 30 ends of
the oppositely transcribed genes do in fact overlap, although
the coding regions do not. We also used predictions of clusters
of liver entyme enriched transcription factor binding sites to
guide our selection of genomic segments for resequencing.
One cluster was predicted with high probability approximately
11.4kb upstream of the CAR transcription start site; a 364
base pair (bp) segment encompassing this region was included
in our survey. A total of 4.1kb were surveyed in each of three
human population samples (African Americans, European
Americans and the Han People of Los Angeles), including
1,051bp of coding sequence and 3,053bp of CNS. The same
segments were sequenced in one chimpanzee, revealing that
human–chimpanzee divergence at CAR is relatively low (0.76
per cent) compared with the genome-wide average of 1.24 per
cent.
36
Summary statistics of sequence variation at the CAR locus
are shown in Table 1. Levels of polymorphism are summarised
by nucleotide diversity (p) — based on the mean number of
pairwise differences between samples — and uW, based on the
number of polymorphic sites and sample size.
39 The frequency
spectrum of polymorphic sites at a given locus is captured by
the Tajima’s D statistic.
40 An excess of rare variants is indicated
by a negative Tajima’s D value, while a positive value signals an
excess of intermediate frequency variants. The Tajima’s D
values observed for the non-African populations are not sig-
niﬁcantly different from zero and indicate that the spectrum of
allele frequencies in these populations is consistent with the
neutral-equilibrium expectation. The more negative Tajima’s
D value observed in the African-American sample may be
reﬂective of recent population growth or admixture between
African and European populations.
41
Many standard neutrality tests are based on the assumption
of populations at equilibrium. Most human populations,
however, do not ﬁt these assumptions, making a comparison
of our results with an empirical distribution a more appro-
priate measure of deviations from neutrality. To this end, we
compared our results with the resequencing data of the
UW-FHCRC Variation Discovery Resource (Seattle SNP).
The European and African-American samples from the Seattle
SNP dataset are the same as those used in our study, resulting
in a direct comparison; however, no Asian data are available
from this project. Our results for nucleotide diversity (p and
uW), Tajima’s D, and uW normalised by human–chimpanzee
divergence (to account for differences in the neutral mutation
rate across loci) were all compared with the distribution of
these values from 159 genes in the Seattle SNP dataset — the
results are shown in Table 1. Although the Tajima’s D value in
the African-American sample is at the low end of the distri-
bution, most of the CAR statistics are well within the range
observed in the larger dataset, suggesting that it evolved largely
according to neutral expectations.
Coding and non-coding sequence variation
We identiﬁed a total of 21 polymorphic sites, including one
singleton 24bp indel. It is interesting that six out of 21 (29 per
cent) single nucleotide polymorphisms (SNPs) occur within
374bp in intron 2, and that ﬁve of the six disrupt predicted
transcription factor binding sites (Table 2). Of the 21 SNPs, 17
fell into non-coding sequence and four into coding, of which
three were synonymous changes and one was non-synon-
ymous. The non-synonymous SNP, Arg97Trp, is located in
the ,20 amino acids comprising the linker region between
the DBD and LBD and results in an intolerant change, as
predicted by SIFT.
27 The Arg97Trp SNP has a SIFT score of
0.00, although, since the amino acid alignment could contain
only mammalian sequences, there was insufﬁcient power to
assign a quality score based on evolutionary conservation.
A predicted exon splice enhancer is also disrupted by the non-
synonymous SNP
28 (data not shown).
The ancestral allele at each polymorphic site was inferred by
comparison to the chimpanzee sequence. Complete conser-
vation of the ancestral allele across the three non-primate
lineages included in our study (carnivore, artiodactyl and
rodent) was observed for eight of the 21 SNPs (excluding sites
where the position was missing in any lineage) (Table 2).
The ancestral haplotype is observed at high frequency in the
African-American sample and is present in the Asian sample.
Table 1. Summary statistics of sequence variation at the CAR locus.
Sample S
a p
b uW
c TD
d uW/div
e
African Americans 16 0.50 (13) 0.89 (33) 21.37 (6) 11.7 (57)
Europeans 12 0.55 (41) 0.66 (9.5) 20.48 (23) 8.7 (78)
Han 6 0.42 0.33 0.72
aNumber of segregating sites.
bNucleotide diversity per base pair (£ 10
23). Numbers in parentheses indicate the percentile rank of p relative to the distribution of p values in the Seattle SNP genes.
cWatterson’s estimator of the population mutation rate parameter u (¼ 4Nm) per bp (£10
23).
37
dTajima’s D (TD).
38 Numbers in parenthesis indicate the percentile rank of the TD value relative to the distribution of TD values in the Seattle SNP genes.
eRatio of uW to the amount of sequence divergence between human and chimpanzee (per cent). Numbers in parenthesis indicate the percentile rank of the uW:div value relative
to the distribution of uW:div values in the Seattle SNP genes.
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Position
a Location Nucleotide present
b Derived allele frequency Possible consequences
c
Human Chimp Cow Dog Rat Mouse AA Han EU
28187 50 sequence G/A G n/a n/a n/a n/a 0.02 0 0 Disrupts NF-1 site
41893 Intron 2 A/G AA G AA 0 0 0.02
42202 Intron 2 G/C GG G – - 0.04 0 0 Disrupts HNF-1 site
42218 Intron 2 T/C TT T C C 0.07 0 0 Disrupts NF-1 site
42221 Intron 2 C/T CC C C C0 0 0.02 Disrupts NF-1 site
42225 Intron 2 C/A CC C C C0.07 0.18 0.21 Disrupts NF-1 site
42267 Intron 2 C/T CC C A A 0.04 0 0 Disrupts C/EBP, USF sites
44896 Intron 3 C/T CC C C C0.29 0.47 0.31
45014 Exon 4 C/G CC C C C0.02 0 0
45045 Exon 4 C/T CC C C C0.02 0 0 Radical NS change; Disrupts
predicted ESE
45518 Exon 5 C/T CC C C G 0.16 0.45 0.42
45567 Intron 5 A/G AA G C G 0.05 0 0.02 Disrupts HNF-1 site
47331 Intron 7 G/- GG – – – 0.02 0 0
47537 Intron 8 A/C A G G C C 0.05 0.15 0.21 Disrupts NF-1 site
47636 Intron 8 T/G TT T T T0.26 0.09 0.23
48318 Intron 8 T/C T n/a – C T 0.02 0 0.02
48342 Intron 8 G/A G n/a C GG 0.04 0 0
48419 Exon 9 G/A G n/a G A A 0 0 0.02
48621 30 sequence G/A G C T C C 0 0 0.02
48692 30 sequence A/T AA T G G 0.02 0 0.02
48734 30 sequence A/T AA A A A0 0.02 0
aPositions are based on the reverse complement of AL50974.
bNucleotides in bold are identical to that observed in chimpanzee. ‘n/a’ denotes missing data, while ‘–’ indicates that the position is absent relative to human.
cTranscription factor binding site predictions are based on output from Match; exon splice enhancer (ESE) predictions are based on predictions from ESEﬁnder (see Methods).
Abbreviations: C/EBP, CCAATenhancer binding protein; HNF, hepatocyte nuclear factor; NF, nuclear factor; USF, upsteam stumulatory factor.
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2Five SNPs have a combined allele frequency of 10 per cent or
higher across all populations, while the remaining 16 are rare.
Four of the ﬁve common SNPs fall in positions that are
conserved across all three non-primate lineages.
If a gene is evolving neutrally, the ratio of within-species
polymorphism to between-species divergence is expected to
be similar across functional classes of sites — for example,
synonymous and non-synonymous sites; deviation from this
expectation can be detected using the McDonald–Kreitman
(MK) test.
42 Any two distinct classes of sites can be assessed in
this format, where skews in the ratio of levels of poly-
morphism and divergence are informative about the type of
selection acting on the locus. The MK test applied to
synonymous and non-synonymous sites was not signiﬁcant.
Next, we applied the test to entire surveyed segments,
including coding and non-coding regions, by partitioning the
sites into two classes deﬁned by cross-species conservation. In
this context, sequence conservation is taken as a measure of
the probability of a site being functionally important. Sites
were classiﬁed as conserved only if the ancestral allele was
conserved across the three non-primate lineages; all other site
conﬁgurations were considered non-conserved. For the
classiﬁcation of ﬁxed differences, the human–chimpanzee
alignment was used to locate all divergent sites; these were
called either conserved or non-conserved, based on the same
criteria as described for the polymorphic sites. We constructed
a2£ 2 table with all polymorphic sites and observed no
signiﬁcant deviations from neutral expectation. Because
slightly deleterious polymorphic sites tend to be rare,
43 we
repeated the test by partitioning the polymorphic sites based
on their frequency. As shown in Table 3, a signiﬁcant deviation
was observed in the distribution of common polymorphisms
(p ¼ 0.02), suggesting different selective pressures on rare
versus common amino acid variants.
Haplotype structure and
interpopulation differentiation
The inferred haplotypes shown in Figure 2 reveal a number of
common haplotypes, but no deﬁned structure overall at this
locus. One haplotype, which is only one step away from the
ancestral, is the most commonly observed among non-African
samples and occurs at high frequency in the African-
Table 3. McDonald–Kreitman test comparing levels of human
polymorphism and divergence between human and chimpanzee at
conserved versus non-conserved sites across distantly related
mammals.
Non-conserved
a Conserved
Rare polymorphic sites
Fixed 19 5
Polymorphic
b 11 4
Common polymorphic sites
Fixed 19 5
Polymorphic 1 4
aIf the allele in chimpanzee (ancestral) was identical to that found in the same position
in rodent, artiodactyl and carnivore, the site was considered conserved across three
lineages.
bThe singleton indel was not included in this analysis.
For Rare polymorphic sites, Fisher’s exact test (FET) p ¼ 0.71; for common poly-
morphic sites, FET p ¼ 0.02; For rare polymorphic sites, polymorphisms identiﬁed in
the resequencing survey were classiﬁed as either rare (minor allele frequency ,10 per
cent in the combined sample) or common (minor allele frequency $10 per cent in the
combined sample).
Figure 2. Inferred haplotypes at CAR. The chimpanzee
sequence was used to infer the ancestral allele at each site,
denoted with a grey box; derived alleles are indicated by black.
The numbers on the right indicate the number of haplotypes in
each population. Numbers across the top indicate the position
of each polymorphic site relative to the reverse complemented
reference sequence (AL50974).
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majority of haplotypes (.90 per cent) contain two or fewer
changes from the ancestral. The strong constraint, as well as
similar nucleotide diversity levels and haplotype structure
across populations, suggests that the forces shaping diversity at
this locus are not population speciﬁc.
The FST statistic, which measures variation in allele fre-
quency between populations, is useful for quantifying inter-
population differentiation.
44 We estimated FST per site
between pairs of population samples. At the CAR locus, only
one SNP identiﬁed in this study has an FST value greater than
the 0.123 average estimated by Akey et al.
45 in a study of
26,530 SNPs in three population samples. The 20 remaining
SNPs fall well below the average, with 18/20 (90 per cent)
having FST values of 0.05 or less. These data conﬁrm that
this locus is not characterised by a high degree of inter-
population differentiation.
Phylogenetic analysis by maximum
likelihood of CAR genes
Previous phylogenetic investigations of CAR genes have only
looked at two-sequence comparisons in calculating v
ratios.
12,46 We performed phylogenetic analysis on amino acid
sequences of several NRs in order to detect deviations in the
rate of amino acid substitutions using PAML. Table 4 shows
the results of PAML analysis of sequence data for CAR and
four other genes in the NR1 family which have complete
sequence data for four or more mammals: TRa, NR1A1;
FXR, NR1H4; VDR, NR1I1; and PXR, NR1I2. A total of
three analyses were performed for each gene: full-length
sequence, DBD only and LBD only.
The analyses for the full-length sequence, DBD and LBD
for the TRa, FXR and VDR genes show low v ratios,
consistent with strong purifying (negative) selection as the
dominant evolutionary force for these genes. The CAR and
PXR analyses, for the full-length sequence and LBD show a
minority of codons (sites) with v ratios approaching one or, in
the case of PXR, exceeding one, however (results in bold in
Table 4). By contrast, the v ratios for the DBD are low for
CAR and PXR. These results illustrate that CAR genes have
an elevated v ratio across the mammalian species for which
CAR sequence data are available, compared with other NR
genes. In this regard, CAR is similar to PXR, a closely
related NR that also responds to diverse exogenous and
endogenous ligands.
Discussion
Our survey of sequence variation at the CAR locus in three
ethnically diverse human populations identiﬁed a number
of polymorphic sites which are likely to affect function,
including four common polymorphisms at highly conserved
sites across distantly related mammalian species and one
amino acid substitution. Most of the SNPs identiﬁed are
rare and population speciﬁc, while the intermediate frequency
SNPs tend to be shared by all three populations at
similar frequencies.
These results suggest that CAR evolved under strong
functional constraints and that interethnic variability in drug
response is not likely to result from genetic variation at this
locus. As an upstream regulator of many genes involved in
drug metabolism and detoxiﬁcation, as well as a regulator of
bilirubin and thyroid hormone metabolism, CAR may be
more likely to be strongly constrained and may not be as
subject to interpopulation differences. The role of CAR in
bile acid homeostasis — a mechanism unlikely to change
across populations — as well as its obligate heterodimerisation
Table 4. Phylogenetic analysis by maximum likelihood (PAML)
models from analysis of sequence data from the CAR, PXR, VDR,
FXR and TRa genes (values in parentheses indicate percentage of
codons falling in a particular v category).
PAML model
CAR (NR1I3)
Full sequence M3, v ¼ 0.03 (51%), 0.47 (49%)
DBD only M0, v ¼ 0.1598
LBD only M3, v ¼ 0.06 (68%), 0.72 (32%)
VDR (NR1I1)
Full sequence M3, v ¼ 0.00001 (77%), 0.333 (23%)
DBD only M0, v ¼ 0.0085
LBD only M3, v ¼ 0.00001 (67%), 0.32 (33%)
PXR (NR1I2)
Full sequence M3, v ¼ 0.049 (79%), 0.666 (21%)
DBD only M0, v ¼ 0.0441
LBD only M3, v ¼ 0.01 (51%), 0.26 (42%), 1.23 (7%)
TRa (NR1I2)
Full sequence M0, v ¼ 0.02
DBD only M0, v ¼ 0.0001
LBD only M0, v ¼ 0.01
FXR (NR1H4)
Full sequence M3, v ¼ 0.00001 (72%), 0.22 (28%)
DBD only M0, v ¼ 0.0137
LBD only M3, v ¼ 0.00001 (83%), 0.295 (17%)
Abbreviations: CAR, constitutive androstane receptor; PXR, pregnane X receptor;
VDR, vitamin D receptor; FXR, farnesoid X receptor; TRa, thyroid receptor-a; DBD,
DNA binding domain; LBD, ligand binding domain.
Thompson et al. Review PRIMARY RESEARCH
q HENRY STEWART PUBLICATIONS 1479–7364. HUMAN GENOMICS. VOL 2. NO 3. 168–178 SEPTEMBER 2005 174with RXR, corroborate the idea that this gene is under strong
evolutionary constraint.
We observed only one non-synonymous variant in our
survey of 70 individuals, suggesting that amino acid
polymorphisms do not contribute to the substantial interin-
dividual variability reported for CAR.
14,15 Alternative splice
forms may underlie considerably more variation with regard
to changes in expression pattern, expression level, protein
binding and function. Many nuclear hormone receptors,
including CAR,
47,48 have alternate splice forms, a mechanism
which presumably offers greater complexity for this class of
genes. No nucleotide variation was observed in any of the
reported sequences spliced into alternate forms of CAR.
Alternatively, variation in the expression level of CAR may be
related to the collective effects of multiple rare polymorph-
isms; combinations of common and rare variation have
recently been demonstrated to contribute to functional
variation
49 and may play an important role in clinical
drug response.
The results of a resequencing survey at PXR revealed
similar ﬁndings with regard to human variation.
50 In this study,
coding regions, as well as the 50 and 30 untranslated regions,
the promoter and 50bp of ﬂanking intronic sequence,
were surveyed in 170 chromosomes; only three non-synon-
ymous SNPs were identiﬁed and two were found at low
frequencies. None of the non-synonymous SNPs were located
in the LBD. The diversity of the CAR and PXR LBDs
between mammalian species, as evidenced by the PAML
results, contrasts with the PXR and CAR resequencing studies
showing very low nucleotide diversity in the CAR coding
region. These results suggest that PXR and CAR may have
critical roles in humans that do not vary across ethnic
groups but that differ with regard to functions and/or ligands
across species.
The disproportionately large number of polymorphisms
located within 374bp of intron 2 is striking and deserves
further investigation. All of these SNPs fall in positions that are
conserved across at least two non-primate lineages, suggesting
a high level of conservation in this region overall. Estimates
of diversiﬁcation times of placental mammals suggest that
rodents, carnivores and artiodactyls shared a common ancestor
approximately 90 million years ago, leading to a total
common ancestry spanning nearly 360 million years,
35
highlighting the potential importance of sequences conserved
across four deep branches of the mammalian phylogeny and
over such a length of evolutionary time. Five of the six SNPs
disrupt predicted liver-enriched transcription factor binding
sites. The results of this analysis suggest that intron 2 may
contain regulatory elements conserved across several mam-
malian lineages.
We observe a skewed distribution of common poly-
morphisms relative to ﬁxed substitutions between human and
chimpanzee at sites highly conserved across distantly related
mammals. This can be interpreted in several ways. One
possibility is that we observe a deﬁcit of polymorphism in
non-conserved sequence, which might indicate increased
evolutionary constraints in humans relative to the other
mammals. Alternatively, the deviation may be due to an excess
of ﬁxed substitutions between human and chimpanzee at
non-conserved sites. Perhaps a more likely explanation is that
the observed deviation is due to an excess of common
polymorphisms at conserved sites, suggesting that they are
maintained at intermediate frequencies across populations.
This implies a functional role for these SNPs. While these
interpretations are highly speculative, they suggest that it may
be interesting to investigate these common variants through
functional assays and association studies.
Overall, our comparative genomics-based survey of
sequence variation at the CAR locus reveals a history largely
characterised by strong evolutionary constraints between
species and across three population samples, with most FST
values falling well below the genome-wide average. Interest-
ingly, however, there is a suggestion in the phylogenetic and
the population genetics analyses that a small portion of sites
might have evolved adaptively. This, coupled with the ﬁnding
of a relatively large number of polymorphic sites in a small
conserved non-coding region in intron 2, provides further
motivation for functional studies of CAR variation.
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Electronic database information
Coriell Cell Repositories, http://locus.umdnj.edu/ccr/
Di Rienzo Lab Web site, http://genapps.uchicago.edu/
labweb/pubs.html (for primer sequences, population sample
information, and data)
GenBank, http://www.ncbi.nlm.nih.gov/Genbank/ (for
CAR [accession number AL509714])
MATCH 1.0, www.gene-regulation.com/cgi-bin/pub/
programs/match/bin/match.cgi (for prediction of transcrip-
tion factor binding sities)
PharmGKB, http://www.pharmgkb.org/ (for primer
sequences and population samples used in resequencing study
[accession number PS203897])
SLIDER, http://genapps.uchicago.edu/slider/index.html
(for computing summary statistics of population genetic data)
University of WashingtonFred Hutchinson Cancer
Research Center, http://pga.gs.washington.edu/education.
html (for SeattleSNPs, the National Heart Lung and Blood
Institute’s Program for Genomic Applications).
Supplementary Table 1. Sequences used in Phylogenetic Analysis by Maximum Likelihood analysis.
Gene Domain Species Accession
a
CAR Full-length Human NM_005122
Rhesus AY116212
Mouse NM_009803
Rat NM_022941
Fur Seal AB109554
Baikal seal AB109553
LBD only Dog AAEX01049487 and AAEX01049488
DBD only Cow 30573, December 10, 2004
PXR Full-length Human NM_003889
Chimpanzee Nov. 2003 chimpanzee Arachne assembly, NCBI
Build 1 version 1, UCSC: panTro1
Rhesus AF454671
Rabbit AF188476
Mouse AF031814
Rat AF151377
LBD only Dog AF454670
Pig AF454672
VDR Full-length Human NM_000376
Cotton-top tamarin AF354232
Mouse NM_009504
Rat NM_017058
DBD only Chimpanzee Nov. 2003 chimpanzee Arachne assembly, NCBI
Build 1 version 1, UCSC: panTro1
TRa Full-length Human NM_003250
(continued)
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Gene Domain Species Accession
a
Sheep Z68308
Pig AJ005797
Rat M18028
Mouse NM_178060
DBD only Chimpanzee Nov. 2003 chimpanzee Arachne assembly, NCBI
Build 1 version 1, UCSC: panTro1
FXR Full-length Human NM_005123
Chimp Nov. 2003 chimpanzee Arachne assembly, NCBI
Build 1 version 1, UCSC: panTro1
Rabbit AF497630
Golder hamster AF478441
Mouse NM_009108
Rat NM_021745
aAll accession number refer to Genbank sequences unless otherwise speciﬁed.
Abbreviations: CAR, constitutive androstane receptor: PXR, pregnane X receptor; VDR, vitamin D receptor; TRa, thyroid receptor-a, FXR, farnesoid X receptor; DBD, DNA
binding domain; LBD, ligand binding domain; NCBI, The National Center for Biotechnology Information; UCSC, The University of California Santa Cruz.
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